Appropriateness of Intravenous Antibiotics Prescriptions at Hospital Discharge
Quasi-experimental Study Comparing Intravenous Antibiotics Prescriptions at Hospital Discharge With and Without ID Consultation
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The pre-intervention period was started from November 1, 2015 to April 30, 2016 (6-month period), in which the intravenous antibiotics at hospital discharge were prescribed by the primary care team. The post-intervention period was started from May 1, 2016 to February 28, 2017 (10-month period), in which the intravenous antibiotics at hospital discharge were reviewed and intervened by ID team.
The appropriateness of intravenous antibiotics was assessed separately by the ID fellow and ID specialist. If disagreement occurred, the feedback to the ID fellow was performed and the decision by ID specialist was used in the final analysis of appropriateness.
In post-intervention period, ID fellow modified the intravenous antibiotics ordered by the primary team if those intravenous antibiotics were judged as inappropriate by ID fellow as follows: 1) discontinue intravenous antibiotics (treatment was complete), 2) switch to oral antibiotics, 3) change intravenous antibiotics to cover isolated pathogens, 4) adjust the dose of intravenous antibiotics, and 5) change the duration of intravenous antibiotics
Finally, ID specialist retrospectively assessed the appropriateness of intravenous antibiotics at hospital discharge managed by ID fellow in post-intervention period.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Chiang Mai, Tailândia, 50200
- Department of Medicine
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
All adult patients who met the following criteria were consecutively enrolled;
- age≥ 15 years old and
- had infections at any sites and received intravenous antibiotics.
Exclusion Criteria:
- They were evaluated by infectious diseases specialist for appropriate antibiotics during admission
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição sequencial
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: pre-intervention period
The charts of patients who were prescribed intravenous antibiotics at hospital discharge were reviewed.
Appropriateness of intravenous antibiotics was assessed by ID specialists.
|
|
|
Experimental: post-intervention period
The intervention is the charts of patients who were prescribed intravenous antibiotics at hospital discharge by the primary team were prospectively reviewed and intervened by ID team (ID specialist approval)
|
Appropriateness of intravenous antibiotics ordered by the primary team was assessed by ID specialist.
ID fellow modified the intravenous antibiotics ordered by the primary team if those intravenous antibiotics were judged as inappropriate by ID fellow as follows: 1) discontinue intravenous antibiotics (treatment was complete), 2) switch to oral antibiotics, 3) change intravenous antibiotics to cover isolated pathogens, 4) adjust the dose of intravenous antibiotics, and 5) change the duration of intravenous antibiotics.
Finally, ID specialist retrospectively assessed the appropriateness of intravenous antibiotics at hospital discharge managed by ID fellow in post-intervention period.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
The proportion of appropriateness of intravenous antibiotics prescriptions at hospital discharge between groups
Prazo: 16 months
|
To calculate the number of antibiotic prescriptions at hospital discharge over the total number of prescriptions, comparing between pre-and post-intervention period.
|
16 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
The costs of antibiotics for the course of treatment
Prazo: 16 months
|
To compare the cost of antibiotics for the course of treatment between the 2 periods
|
16 months
|
|
Clinical improvement at 1 week
Prazo: 1 week
|
To calculate the number of patients who had clinical improvement at 1 week over the total number of patients in each period, comparing between the 2 periods
|
1 week
|
|
Readmission within 30 days, length of hospital stay
Prazo: 30 days
|
To calculate the number of patients who were readmitted within 30 days over the total number of patients in each period, comparing between the 2 periods
|
30 days
|
|
Length of hospital stay
Prazo: 60 days
|
To calculate the length of hospital stays in days between 2 periods
|
60 days
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Romanee Chaiwarith, MD, Maharaj Nakorn Chiang Mai Hospital
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 3631
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em ID specialist approval
-
West Virginia UniversityAtivo, não recrutandoTranstorno de Abuso de SubstânciasEstados Unidos
-
Portsmouth Hospitals NHS TrustBritish Lung Foundation; University of OxfordConcluídoMesotelioma, MalignoReino Unido, Austrália
-
PulseMedicaConcluído
-
PulseMedicaConcluído
-
Abbott Rapid DxAinda não está recrutandoCondição Assintomática | Infecção por Neisseria Gonorrheae | Infecção por Chlamydia TrachomatisEstados Unidos
-
Seoul National University HospitalDesconhecidoMovimento intestinal anormal, como constipação, diarreia, dor abdominalRepublica da Coréia
-
University Hospital, LilleMinistry of Health, FranceConcluídoObesidade | GravidezFrança
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; AstraZenecaConcluídoCovid19 | Asma | Ataque de asma | Asma PersistenteReino Unido
-
National Cancer Center, KoreaBoston Scientific CorporationRecrutamentoRadioterapia | Carcinoma de Trato Biliar | Remoção por radiofrequênciaRepublica da Coréia
-
University Hospital, MontpellierAtivo, não recrutandoAVC Isquêmico | Enxaqueca | Enxaqueca Com AuraFrança